ASCO
Audio Journal of Oncology in Advance - April 1st, 2007 - reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006

George Canellos

Robert Motzer
Hormone Replacement Therapy: Better Survival With Colorectal Cancer
REFERENCE: J Clin Oncol 24:5680-5686
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
Using postmenopausal estrogen replacement before the diagnosis of colorectal cancer was associated with better cancer-specific and overall mortality. This is the finding of a study by Jennifer Chan and colleagues from the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston. Peter Goodwin talked with George Canellos about the finding and its implications for therapy.
High-Dose Chemotherapy With Stem Cell Rescue: No Benefit as First-Line Therapy in Metastatic Germ Cell Tumors
REFERENCE: J Clin Oncol 25: 247-256
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
No advantage has emerged from high-dose chemotherapy as first-line therapy in patients with poor- and intermediate-risk metastatic germ cell tumors. A phase III randomized study comparing high-dose with standard-dose chemotherapy has been published in the Journal of Clinical Oncology by a group led by Robert Motzer of Memorial Sloan-Kettering Cancer Center in New York. George Canellos discusses these findings with Peter Goodwin and puts them into context with other recent related study findings.
Similar Interviews
Audio Journal of Oncology 13.3, April 2005
Reporting from:
- American Society of Hematology 46th Annual Meeting, December 4-7, 2004, San Diego
- San Antonio Breast Cancer Symposium, December
Audio Journal of Oncology in Advance - April 15th, 2007 - Bisphosphonates Recommended for Lung Cancer Bone Metastases
PETER HARPER, Guy’s Hospital, London
REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville
Bisphosphonates may be
Audio Journal of Oncology in Advance - January 15th, 2007 - HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer
IAN SMITH, Royal Marsden Hospital, London
REFERENCE: Lancet 369:29
Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast
[...] Original post by admin [...]
[...] David Rothman wrote an interesting post today onHere’s a quick excerptGeorge Canellos discusses these findings with Peter Goodwin and puts them into context with other recent related study findings. To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations. [...]